Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Outlook Therapeutics Inc (NASDAQ: OTLK) closed at $1.21 in the last session, down -6.92% from day before closing price of $1.3. In other words, the price has decreased by -$6.92 from its previous closing price. On the day, 0.63 million shares were traded. OTLK stock price reached its highest trading level at $1.3 during the session, while it also had its lowest trading level at $1.21.
Ratios:
We take a closer look at OTLK’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.54 and its Current Ratio is at 0.67.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OTLK now has a Market Capitalization of 53747632 and an Enterprise Value of 79544520. For the stock, the TTM Price-to-Sale (P/S) ratio is 35.60. Its current Enterprise Value per Revenue stands at 52.842 whereas that against EBITDA is -1.097.
Stock Price History:
The Beta on a monthly basis for OTLK is 0.22, which has changed by -0.8003072 over the last 52 weeks, in comparison to a change of 0.15566266 over the same period for the S&P500. Over the past 52 weeks, OTLK has reached a high of $6.98, while it has fallen to a 52-week low of $0.79. The 50-Day Moving Average of the stock is 1.58%, while the 200-Day Moving Average is calculated to be -24.80%.
Shares Statistics:
According to the various share statistics, OTLK traded on average about 3.79M shares per day over the past 3-months and 850610 shares per day over the past 10 days. A total of 43.48M shares are outstanding, with a floating share count of 29.09M. Insiders hold about 34.52% of the company’s shares, while institutions hold 13.64% stake in the company. Shares short for OTLK as of 1760486400 were 2168058 with a Short Ratio of 0.57, compared to 1757894400 on 5354593. Therefore, it implies a Short% of Shares Outstanding of 2168058 and a Short% of Float of 5.9299998.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 4.0 analysts currently analyzing and rating the stock of Outlook Therapeutics Inc (OTLK).The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.09 and low estimates of -$0.33.
Analysts are recommending an EPS of between -$1.72 and -$1.92 for the fiscal current year, implying an average EPS of -$1.84. EPS for the following year is -$1.01, with 4.0 analysts recommending between -$0.28 and -$1.67.
Revenue Estimates
For the next quarter, 4 analysts are estimating revenue of $4.4M. There is a high estimate of $5M for the next quarter, whereas the lowest estimate is $3.8M.
Based on 5 analysts’ estimates, the company’s revenue will be $29.78M in the next fiscal year. The high estimate is $60.88M and the low estimate is $15.92M.
